The problem of cardio-renal diseases in patients with gout

References

• Tomiyama H, Higashi Y, Takase B, et al. Relationships among hyperuricemia, metabolic syndrome, and endothelial function. Am J Hypertens 2011;24:770-4
   Web of Science ®Google Scholar
• Feig DI. The role of uric acid in the pathogenesis of hypertension in the young. J Clin Hypertens (Greenwich) 2012;14:346-52
   PubMed Web of Science ®Google Scholar
• Lv Q, Meng XF, He FF, et al. High serum uric acid and increased risk of type 2 diabetes: a systemic review and meta-analysis of prospective cohort studies. PLoS One 2013;8:e56864
   PubMed Web of Science ®Google Scholar
• Zoppini G, Targher G, Chonchol M, et al. Serum uric acid levels and incident chronic kidney disease in patients with type 2 diabetes and preserved kidney function. Diabetes Care 2012;35:99-104
   PubMed Web of Science ®Google Scholar
• Stack AG, Hanley A, Casserly LF, et al. Independent and conjoint associations of gout and hyperuricaemia with total and cardiovascular mortality. QJM 2013;106:647-58
   PubMed Web of Science ®Google Scholar
• Borghi C, Rosei EA, Bardin T, et al. Serum uric acid and the risk of cardiovascular and renal disease. J Hypertens 2015;33:1729-41
   PubMed Web of Science ®Google Scholar
• Chen C, Lü JM, Yao Q, et al. Hyperuricemia-related diseases and xanthine oxidoreductase (XOR) inhibitors: an overview. Med Sci Monit 2016;22:2501-12
   PubMed Web of Science ®Google Scholar
• Hille R, Nishino T. Flavoprotein structure and mechanism. 4. Xanthine oxidase and xanthine dehydrogenase. FASEB J 1995;9:995-1003
   PubMed Web of Science ®Google Scholar
• Hellsten-Westing Y. Immunohistochemical localization of xanthine oxidase in human cardiac and skeletal muscle. Histochemistry 1993;100:215-22
   PubMedGoogle Scholar
• Cejková J, Ardan T, Filipec M, et al. Xanthine oxidoreductase and xanthine oxidase in human cornea. Histol Histopathol 2002;17:755-60
   PubMed Web of Science ®Google Scholar
• Linder N, Rapola J, Raivio KO. Cellular expression of xanthine oxidoreductase protein in normal human tissues. Lab Investig 1999;79:967-74
   PubMed Web of Science ®Google Scholar
• Malik UZ, Hundley NJ, Romero G, et al. Febuxostat inhibition of endothelial-bound XO: implications for targeting vascular ROS production. Free Radic Biol Med 2011;51:179-84
   PubMed Web of Science ®Google Scholar
• Feig DI, Soletsky B, Johnson RJ. Effect of allopurinol on the blood pressure of adolescents with newly diagnosed essential hypertension. JAMA 2008;300:924-32
   PubMed Web of Science ®Google Scholar
• Niskanen LK, Laaksonen DE, Nyyssönen K, et al. Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-aged men: a prospective cohort study. Arch Intern Med 2004;164:1546-51
   PubMed Web of Science ®Google Scholar
• Fang J, Alderman MH. Serum uric acid and cardiovascular mortality: the NHANES I epidemiologic follow-up study, 1971–1992. JAMA 2000;283:2404-10
   PubMed Web of Science ®Google Scholar
• Alderman MH, Cohen H, Madhavan S, et al. Serum uric acid and cardiovascular events in successfully treated hypertensive patients. Hypertension 1999;34:144-50
   PubMed Web of Science ®Google Scholar
• Niskanen L, Laaksonen DE, Lindström J, et al. Serum uric acid as a harbinger of metabolic outcome in subjects with impaired glucose tolerance: the Finnish diabetes prevention study. Diabetes Care 2006;29:709-11
   PubMed Web of Science ®Google Scholar
• Iseki K, Ikemiya Y, Inoue T, et al. Significance of hyperuricemia as a risk factor for developing ESRD in a screened cohort. Am J Kidney Dis 2004;44:642-50
   PubMed Web of Science ®Google Scholar
• Iseki K, Oshiro S, Tozawa M, et al. Significance of hyperuricemia on the early detection of renal failure in a cohort of screened subjects. Hypertens Res 2001;24:691-7
   PubMed Web of Science ®Google Scholar
• Tomita M, Mizuno S, Yamanaka H, et al. Does hyperuricemia affect mortality? A prospective cohort study of Japanese male workers. J Epidemiol 2000;10:403-9
   PubMedGoogle Scholar
• Krishnan E, Kwoh CK, Schumacher HR, et al. Hyperuricemia and incidence of hypertension among men without metabolic syndrome. Hypertension 2007;49:298-303
   PubMed Web of Science ®Google Scholar
• Jossa F, Farinaro E, Panico S, et al. Serum uric acid and hypertension: the Olivetti Heart Study. J Hum Hypertens 1994;8:677-81
   PubMed Web of Science ®Google Scholar
• Forman JP, Choi H, Curhan GC. Plasma uric acid level and risk for incident hypertension among men. J Am Soc Nephrol 2007;18:287-92
   PubMed Web of Science ®Google Scholar
• Nakanishi N, Okamoto M, Yoshida H, et al. Serum uric acid and risk for development of hypertension and impaired fasting glucose or Type II diabetes in Japanese male office workers. Eur J Epidemiol 2003;18:523-30
   PubMed Web of Science ®Google Scholar
• Dehghan A, van Hoek M, Sijbrands EJ, et al. High serum uric acid as a novel risk factor for type 2 diabetes. Diabetes Care 2008;31:361-2
   PubMed Web of Science ®Google Scholar
• Siu YP, Leung KT, Tong MK, et al. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level. Am J Kidney Dis 2006;47:51-9
   PubMed Web of Science ®Google Scholar
• Talaat KM, el-Sheikh AR. The effect of mild hyperuricemia on urinary transforming growth factor beta and the progression of chronic kidney disease. Am J Nephrol 2007;27:435-40
   PubMed Web of Science ®Google Scholar
• Kanbay M, Ozkara A, Selcoki Y, et al. Effect of treatment of hyperuricemia with allopurinol on blood pressure, creatinine clearence, and proteinuria in patients with normal renal functions. Int Urol Nephrol 2007;39:1227-33
   PubMed Web of Science ®Google Scholar
• Culleton BF, Larson MG, Kannel WB, et al. Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study. Ann Intern Med 1999;131:7-13
   PubMed Web of Science ®Google Scholar
• Capuano V, Marchese F, Capuano R, et al. Hyperuricemia as an independent risk factor for major cardiovascular events: a 10-year cohort study from Southern Italy. J Cardiovasc Med (Hagerstown) 2017;18:159-64
   PubMed Web of Science ®Google Scholar
• Mazza A, Lenti S, Schiavon L, et al. Asymptomatic hyperuricemia is a strong risk factor for resistant hypertension in elderly subjects from general population. Biomed Pharmacother 2017;86:590-4
   PubMed Web of Science ®Google Scholar
• Prasad M, Matteson EL, Herrmann J, et al. Uric acid is associated with inflammation, coronary microvascular dysfunction, and adverse outcomes in postmenopausal women. Hypertension 2017;69:236-42
   PubMed Web of Science ®Google Scholar
• Ramirez-Sandoval JC, Sanchez-Lozada LG, Magdalena Madero M, et al. Uric acid, vascular stiffness, and chronic kidney disease: is there a link? Blood Purif 2017;43:189-95
   PubMed Web of Science ®Google Scholar
• Canepa M, Viazzi F, Strait JB, et al. Longitudinal association between serum uric acid and arterial stiffness: results from the Baltimore longitudinal study of aging. Hypertension 2017;69:228-35
   PubMed Web of Science ®Google Scholar
• Ticinesi A, Lauretani F, Ceda GP, et al. Uric acid and endothelial function in elderly community-dwelling subjects. Exp Gerontol 2017;89:57-63
   PubMed Web of Science ®Google Scholar
• Nossent J, Raymond W, Divitini M, et al. Asymptomatic hyperuricemia is not an independent risk factor for cardiovascular events or overall mortality in the general population of the Busselton Health Study. BMC Cardiovasc Disord 2016;16:256
   PubMed Web of Science ®Google Scholar
• Kanji T, Gandhi M, Clase CM, et al. Urate lowering therapy to improve renal outcomes in patients with chronic kidney disease: systematic review and meta-analysis. BMC Nephrology 2015;16:58
   PubMed Web of Science ®Google Scholar
• Ciarla S, Struglia M, Giorgini P, et al. Serum uric acid levels and metabolic syndrome. Arch Physiol Biochem 2014;120:119-22
   PubMed Web of Science ®Google Scholar
• Ciarla S, Giorgini P, Struglia M, et al. Associations between low levels of serum uric acid and cardiometabolic parameters. Arch Physiol Biochem 2015;121:139-43
   PubMed Web of Science ®Google Scholar
• Desideri G, Castaldo G, Lombardi A, et al. Is it time to revise the normal range of serum uric acid levels? Eur Rev Med Pharmacol Sci 2014;18:1295-306
   PubMed Web of Science ®Google Scholar